| Ceruletide | hsa00071 | Fatty acid degradation | 4.66E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | |
| Ceruletide | hsa00280 | Valine, leucine and isoleucine degradation | 4.31E-02 | 2 | P26440, Q02252 | IVD, ALDH6A1 | More | |
| Ceruletide | hsa00500 | Starch and sucrose metabolism | 2.61E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
| Ceruletide | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.29E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | |
| Ceruletide | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | |
| Ceruletide | hsa00860 | Porphyrin and chlorophyll metabolism | 5.29E-03 | 2 | P53004, P30043 | BLVRA, BLVRB | More | |
| Ceruletide | hsa00970 | Aminoacyl-tRNA biosynthesis | 1.17E-02 | 3 | O95363, P14868, Q15046 | FARS2, DARS, KARS | More | |
| Ceruletide | hsa03040 | Spliceosome | 6.28E-03 | 6 | Q14562, O43143, O60508, Q07955, Q01130, Q13243 | DHX8, DHX15, CDC40, SFRS1, SFRS2, SFRS5 | More | |
| Ceruletide | hsa03450 | Non-homologous end-joining | 4.32E-02 | 1 | Q9NP87 | POLM | More | |
| Ceruletide | hsa04024 | cAMP signaling pathway | 4.38E-02 | 4 | P42338, P0DP23, Q13370, Q13009 | PIK3CB, CALM1, PDE3B, TIAM1 | More | |
| Ceruletide | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | |
| Ceruletide | hsa04070 | Phosphatidylinositol signaling system | 4.86E-02 | 3 | P0DP23, P42338, P27987 | CALM1, PIK3CB, ITPKB | More | |
| Ceruletide | hsa04072 | Phospholipase D signaling pathway | 9.70E-03 | 2 | Q92529, Q14344 | SHC3, GNA13 | More | |
| Ceruletide | hsa04120 | Ubiquitin mediated proteolysis | 2.57E-02 | 4 | Q14145, Q13042, Q93034, Q15751 | KEAP1, CDC16, CUL5, HERC1 | More | |
| Ceruletide | hsa04360 | Axon guidance | 1.71E-02 | 4 | P20827, O95631, P42338, P23528 | EFNA1, NTN1, PIK3CB, CFL1 | More | |
| Ceruletide | hsa04612 | Antigen processing and presentation | 2.18E-03 | 9 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P30511, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, HLA-F, TNF | More | |
| Ceruletide | hsa04621 | NOD-like receptor signaling pathway | 3.24E-02 | 4 | P52630, P10599, P01375, P12838 | STAT2, TXN, TNF, DEFA4 | More | |
| Ceruletide | hsa04625 | C-type lectin receptor signaling pathway | 2.17E-02 | 3 | P52630, P20749, P01375 | STAT2, BCL3, TNF | More | |
| Ceruletide | hsa04650 | Natural killer cell mediated cytotoxicity | 1.38E-02 | 8 | P78314, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | SH3BP2, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | |
| Ceruletide | hsa04657 | IL-17 signaling pathway | 3.06E-02 | 3 | P49841, P80188, P01375 | GSK3B, LCN2, TNF | More | |
| Ceruletide | hsa04659 | Th17 cell differentiation | 4.38E-02 | 4 | P42224, P14784, P40189, P08238 | STAT1, IL2RB, IL6ST, HSP90AB1 | More | |
| Ceruletide | hsa04660 | T cell receptor signaling pathway | 1.81E-02 | 8 | O95267, Q08881, P20963, P09693, P01732, Q13191, Q16539, P49841 | RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, MAPK14, GSK3B | More | |
| Ceruletide | hsa04666 | Fc gamma R-mediated phagocytosis | 3.08E-02 | 3 | P42338, P23528, P14598 | PIK3CB, CFL1, NCF1 | More | |
| Ceruletide | hsa04730 | Long-term depression | 3.52E-02 | 1 | Q14344 | GNA13 | More | |
| Ceruletide | hsa04914 | Progesterone-mediated oocyte maturation | 3.92E-02 | 3 | P42338, Q13370, P08238 | PIK3CB, PDE3B, HSP90AB1 | More | |
| Ceruletide | hsa04924 | Renin secretion | 3.77E-02 | 2 | Q13370, P0DP23 | PDE3B, CALM1 | More | |
| Ceruletide | hsa04940 | Type I diabetes mellitus | 1.58E-02 | 2 | P30511, P01375 | HLA-F, TNF | More | |
| Ceruletide | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | |
| Ceruletide | hsa05144 | Malaria | 3.30E-02 | 4 | P60033, O60603, P35443, P26718 | CD81, TLR2, THBS4, KLRK1 | More | |
| Ceruletide | hsa05160 | Hepatitis C | 9.27E-03 | 4 | P52630, P60033, P49841, P01375 | STAT2, CD81, GSK3B, TNF | More | |
| Ceruletide | hsa05165 | Human papillomavirus infection | 1.76E-02 | 5 | P49841, P24821, P01375, P52630, P30511 | GSK3B, TNC, TNF, STAT2, HLA-F | More | |
| Ceruletide | hsa05168 | Herpes simplex virus 1 infection | 1.15E-02 | 8 | P42224, Q07955, Q01130, Q13243, P42338, Q13398, Q03923, Q9UDV6 | STAT1, SFRS1, SFRS2, SFRS5, PIK3CB, ZNF211, ZNF85, ZNF212 | More | |
| Ceruletide | hsa05200 | Pathways in cancer | 3.92E-02 | 9 | P42338, P08238, P42224, P43246, P14923, O75293, P0DP23, P14784, P40189 | PIK3CB, HSP90AB1, STAT1, MSH2, JUP, GADD45B, CALM1, IL2RB, IL6ST | More | |
| Ceruletide | hsa05212 | Pancreatic cancer | 1.72E-02 | 3 | P42338, P42224, O75293 | PIK3CB, STAT1, GADD45B | More | |
| Ceruletide | hsa05214 | Glioma | 1.72E-02 | 3 | P0DP23, P42338, O75293 | CALM1, PIK3CB, GADD45B | More | |
| Ceruletide | hsa05225 | Hepatocellular carcinoma | 1.85E-02 | 2 | Q92529, P51531 | SHC3, SMARCA2 | More | |
| Ceruletide | hsa05310 | Asthma | 9.71E-03 | 2 | P12724, P01375 | RNASE3, TNF | More | |
| Ceruletide | hsa05330 | Allograft rejection | 2.30E-02 | 2 | P30511, P01375 | HLA-F, TNF | More | |
| Ceruletide | hsa05332 | Graft-versus-host disease | 3.14E-02 | 2 | P30511, P01375 | HLA-F, TNF | More | |
| Ceruletide | hsa05418 | Fluid shear stress and atherosclerosis | 4.54E-03 | 7 | P42338, Q14145, P14598, P10599, P01375, P0DP23, P08238 | PIK3CB, KEAP1, NCF1, TXN, TNF, CALM1, HSP90AB1 | More | |
